Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Advanced Solid Tumours 5Ovarian Neoplasms 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Solid Tumors 1Previously Treated Non Small Cell Lung Cancer 1Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1Muscle Invasive Bladder Cancer 1Lung Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Advanced Solid Tumors 1

Interventions

pegfilgrastim 1adavosertib 1Antimitotic Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Previously Treated Non Small Cell Lung Cancer × adavosertib × Clear all
NCT02087176 2016-06-14

A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer

AstraZeneca

Phase 2 Terminated
48 enrolled 11 charts
Thoracic

Previously Treated Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡